Daniel Eisenkraft Klein

Daniel Eisenkraft Klein, PhD, MSc is a postdoctoral research fellow at the Program On Regulation, Therapeutics, And Law at Harvard Medical School and Brigham and Women's Hospital. He is also an Affiliate and Course Instructor at the Harvard Medical School’s Center for Bioethics.

His program of work primarily focuses on pharmaceutical and health governance and ethics, with a particular emphasis on how stakeholder input is solicited, structured, and weighted across regulatory and policy settings. A second thread of his research examines drug policy more broadly, with a focus on how medical, commercial, and criminal law systems converge in the regulation of substances such as opioids, nicotine, and psychedelics.

His work has been published in American Journal of Public Health, The American Journal of Bioethics, Social Science & Medicine, JAMA Internal Medicine, and the Journal of Health Politics, Policy and Law, among others.

Daniel received his undergraduate degree from McGill University and his MSc and PhD from the University of Toronto, where he was a Social Sciences and Humanities Research Council Doctoral Fellow. He previously served as a Policy Analyst for Health Canada.